Current Status
Not Enrolled
Get Started

This e-learning Session will discuss the immune mechanisms that play a role in COVID-19 as well as the role of serologic testing for diagnostic purposes. The potential of immunomodulatory treatments currently in clinical trials will be assessed.

Learning Objectives

  1. To discuss the assessment of the high-risk patient in terms of impaired host defense (either due to decreased antiviral immunity or due to hyper-inflammatory phenotype)
  2. To discuss how the use of CRP may be used to identify high-risk patients
  3. To highlight how the empiric off-label immunomodulator use in high-risk patients may decrease burden on healthcare system
Partner Organisation/Institution National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
Medical Association of Malta as representative of UEMS 0.5 Credits
Malta College of Family Doctors Malta College of Family Doctors  0.5 Credits